柳胺苄心定(Labetalol)以下简称 Lab)是一种兼具α受体阻滞作用的新型(?)受体阻滞剂,国外于70年代早期合成,1975年起广泛用于治疗各种类型高血压,国内于1978年研制成功。1981年起开始临床应用。至今Lab 已经得到广泛的基础及临床研究,大量资料证实 Lab 口服对轻、中、重度高血压都有 Labetalol (hereinafter referred to as Lab) is a novel (?) Receptor blocker with both alpha blockers synthesized abroad in the early 1970s and has been widely used since 1975 to treat various Type of hypertension, developed in 1978 in China. Beginning in 1981 clinical application. So far Lab has got a wide range of basic and clinical research, a large number of data confirm that Lab oral for light, moderate and severe hypertension have